로딩 중…
지수 로딩 중…
Praxis Precision Medicines, Inc.
PRAX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$305.51-0.75%
2026-08-03
Financials
Valuation Metrics
Praxis Precision Medicines, Inc.'s Market Cap is $8.52B. At end of 2025 it was $6.63B. Ranked #1040 of 3,112 in US market (top 33%), #338 of 1,445 on NASDAQ (top 23%), #52 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 19%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $8.52B | US#1,040/3,112 Sec#52/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-327M | US—/3,112 Sec—/269 |
| Total Assets | $1.46B | US#2,243/3,112 Sec#67/269 |
| Net Assets | $1.41B | US#1,524/3,112 Sec#47/269 |
| Value | ||
| P/B | 6.04x | US#2,316/3,112 Sec#158/269 |
| FCF Yield | -3.32% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -23.16% | US#2,560/3,112 Sec#110/269 |
| ROA | -22.36% | US#2,800/3,112 Sec#132/269 |
| Revenue Growth | -100.00% | US#2,948/3,112 Sec#190/269 |
| Financial Health | ||
| Debt Ratio | 3.56% | US#29/3,112 Sec#7/269 |
| Total Debt | $1M | US#2,919/3,112 Sec#240/269 |
| FCF | $-283M | US#2,776/3,112 Sec#234/269 |
| Cash | $536M | US#1,035/3,112 Sec#52/269 |
| Current Ratio | 15.88x | US#156/3,112 Sec#49/269 |
| Performance | ||
| 1Y Return | 464.82% | US#13/3,112 Sec#6/269 |
| 1M Return | -4.08% | US#2,149/3,112 Sec#119/269 |
| From 52W High | -16.65% | US#1,511/3,112 Sec#90/269 |
| 1Y MDD | -36.32% | US#1,765/3,112 Sec#123/269 |
| Trading | ||
| Volume | 310,801 shares | US#2,396/3,112 Sec#233/269 |
| Trading Value | $94M | US#953/3,112 Sec#57/269 |
| Per Share | ||
| EPS | $-13.48 | US—/3,112 Sec—/269 |
| BPS | $39.02 | US#610/3,112 Sec#13/269 |